Prostate cancer and microfluids

Area of Science:

• Biomedical Engineering
• Oncology
• Nanotechnology

Background:

• Microfluidic systems enable high-sensitivity, high-resolution detection of biological samples at a small scale.
• The application of microfluidics in medicine is rapidly expanding, particularly for prostate cancer diagnosis and management.
• Microfluidics facilitates point-of-care testing, enhancing accessibility and speed in clinical settings.

Purpose of the Study:

• To review current research on microfluidic systems for prostate cancer diagnosis and management.
• To analyze advancements in detecting prostate-specific antigen, proteins, and circulating tumor cells using microfluidics.
• To explore microfluidic applications in understanding prostate cancer physiology and aiding treatment, including micro-environment creation.

Main Methods:

• Review of existing literature on microfluidics in prostate cancer research.
• Analysis of diagnostic techniques utilizing microfluidic systems.
• Examination of therapeutic strategies employing microfluidic approaches.

Main Results:

• Microfluidic systems show significant promise in detecting key prostate cancer biomarkers like prostate-specific antigen (PSA).
• Advancements include the analysis of proteins and circulating tumor cells (CTCs) for improved diagnostic accuracy.
• Microfluidic platforms are being developed to model the tumor micro-environment and aid treatment strategies.

Conclusions:

• Microfluidic systems offer a versatile platform with vast scope for prostate cancer research and clinical application.
• These technologies are poised to drive significant advancements in the future management of prostate cancer.
• Future roles include exosomal analysis, further enhancing diagnostic and therapeutic capabilities.